Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Toops Dana S"'
Autor:
Richard C. Thomas, Matthew J Zaya, Barbachyn Michael R, Wade J. Adams, Betty H. Yagi, Michael A. Wynalda, J P Sams, Larry C. Wienkers, Ford Charles W, J Gregory Slatter, Nancee L. Oien, William Watt, Eric P. Seest, Janice M. Friis, Joel Morris, Judith C. Hamel, Gary E. Zurenko, Lester A. Dolak, Ronda D. Schaadt, Douglas Stapert, Cleek Gary J, Donn G. Wishka, Stuart A. Garmon, Toops Dana S
Publikováno v:
Journal of Medicinal Chemistry. 46:284-302
A new and promising group of antibacterial agents, collectively known as the oxazolidinones and exemplified by linezolid (PNU-100766, marketed as Zyvox), have recently emerged as important new therapeutic agents for the treatment of infections caused
Autor:
Betty H. Yagi, Suzanne E. Glickman, Susan K. Hendges, Ford Charles W, Toops Dana S, Jonda D. Schaadt, Barbachyn Michael R, Douglas Stapert, Kevin C. Grega, Jerry M. Buysse, Judith C. Hamel, James O. Kilburn, Gary E. Zurenko, William F. Demyan
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 6:1009-1014
Various electron-withdrawing groups were incorporated into the meta position of tropone-substituted 3-phenyl-2-oxazolidinones and their influence on antibacterial activity examined. Consideration of in vitro and in vivo test results indicated that on
Autor:
Sally P. Klemens, Toops Dana S, James O. Kilburn, Susan K. Hendges, Ford Charles W, S. E. Glickman, Gary E. Zurenko, Kevin C. Grega, Steven J. Brickner, Michael H. Cynamon, Hutchinson Douglas K, Barbachyn Michael R
Publikováno v:
Journal of Medicinal Chemistry. 39:680-685
During the course of our investigations in the oxazolidinone antibacterial agent area, we have identified a subclass with especially potent in vitro activity against mycobacteria. The salient structural feature of these oxazolidinone analogues, 6 (U-
Autor:
Susan K. Hendges, Toops Dana S, Hutchinson Douglas K, Manninen Peter Rudolph, Barbachyn Michael R, Gary E. Zurenko, Stuart A. Garmon, Steven J. Brickner, Ford Charles W, Kevin C. Grega, Debra A. Ulanowicz
Publikováno v:
Journal of Medicinal Chemistry. 39:673-679
Bacterial resistance development has become a very serious clinical problem for many classes of antibiotics. The 3-aryl-2-oxazolidinones are a relatively new class of synthetic antibacterial agents, having a new mechanism of action which involves ver
Autor:
Toops Dana S, Barbachyn Michael R
Publikováno v:
The Journal of Organic Chemistry. 58:6505-6508
Autor:
Raymond J. Reid, Gary E. Zurenko, Ronda D. Schaadt, Barbachyn Michael R, John W. Allison, Toops Dana S, Hutchinson Douglas K, Betty H. Yagi
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 3:671-676
Incorporation of a bicyclo[1.1.1]pent-1-yl group at the N-1 position of quinolone antibacterial agents affords compounds with potent activity. One of these analogs, U-87947E, exhibits enhanced activity relative to that of ciprofloxacin against gram-p
Autor:
Ronda D. Schaadt, Betty H. Yagi, R. J. Reid, J. W. Allison, Gary E. Zurenko, Toops Dana S, Barbachyn Michael R, Hutchinson Douglas K
Publikováno v:
ChemInform. 26
Autor:
Betty H. Yagi, Kevin C. Grega, Ronda D. Schaadt, W. F. Demyan, Toops Dana S, Gary E. Zurenko, Steven J. Brickner, J. O. Kilburn, Barbachyn Michael R, Debra A. Ulanowicz, Ford Charles W, S. E. Glickman, Judith C. Hamel, J. M. Buysse, Douglas Stapert
Publikováno v:
ChemInform. 27
Autor:
Susan K. Hendges, Kevin C. Grega, Hutchinson Douglas K, Gary E. Zurenko, Manninen Peter Rudolph, Toops Dana S, Stuart A. Garmon, Ford Charles W, Steven J. Brickner, Debra A. Ulanowicz, Barbachyn Michael R
Publikováno v:
ChemInform. 27
Bacterial resistance development has become a very serious clinical problem for many classes of antibiotics. The 3-aryl-2-oxazolidinones are a relatively new class of synthetic antibacterial agents, having a new mechanism of action which involves ver
Autor:
Michael H. Cynamon, Steven J. Brickner, Susan K. Hendges, Sally P. Klemens, Hutchinson Douglas K, Gary E. Zurenko, James O. Kilburn, S. E. Glickman, Barbachyn Michael R, Kevin C. Grega, Ford Charles W, Toops Dana S
Publikováno v:
ChemInform. 27
During the course of our investigations in the oxazolidinone antibacterial agent area, we have identified a subclass with especially potent in vitro activity against mycobacteria. The salient structural feature of these oxazolidinone analogues, 6 (U-